Skip to main content
EJNMMI Reports

Table 2 Multivariate analysis

From: Tumor heterogeneity measurement using [18F] FDG PET/CT shows prognostic value in patients with non-small cell lung cancer

 

Hazard Ratio

p-value

R-sq

C

Age

1.0333

0.8303

0.4503

0.7531

Sex

1.9773

0.0281

  

SUVmax

1.3563

0.0329

  

Stage II

8.7036

0.0018

  

Stage III

10.3671

0.0002

  

Stage IV

20.2719

< 0.0001

  

HET

1.4287

0.0152

  
Back to article page